Júlio César Rocha Selected Research

Phenylketonurias (Phenylketonuria)

2/2022	The Impact of the Quality of Nutrition and Lifestyle in the Reproductive Years of Women with PKU on the Long-Term Health of Their Children.
2/2022	In Vivo Metabolic Responses to Different Formulations of Amino Acid Mixtures for the Treatment of Phenylketonuria (PKU).
11/2021	Special Low Protein Foods Prescribed in England for PKU Patients: An Analysis of Prescribing Patterns and Cost.
9/2021	Is the Phenylalanine-Restricted Diet a Risk Factor for Overweight or Obesity in Patients with Phenylketonuria (PKU)? A Systematic Review and Meta-Analysis.
9/2021	Unveiling the Metabolic Effects of Glycomacropeptide.
1/2021	Development of a practical dietitian road map for the nutritional management of phenylketonuria (PKU) patients on pegvaliase.
1/2021	Continuous use of glycomacropeptide in the nutritional management of patients with phenylketonuria: a clinical perspective.
11/2020	Protein Labelling Accuracy for UK Patients with PKU Following a Low Protein Diet.
10/2020	A 3 Year Longitudinal Prospective Review Examining the Dietary Profile and Contribution Made by Special Low Protein Foods to Energy and Macronutrient Intake in Children with Phenylketonuria.
9/2020	The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Júlio César Rocha Research Topics

Disease

26	Phenylketonurias (Phenylketonuria) 02/2022 - 01/2010
4	Obesity 09/2021 - 07/2011
3	COVID-19 10/2021 - 01/2020
2	Infections 10/2021 - 01/2020
2	Overweight 09/2021 - 07/2011
2	Malnutrition (Nutritional Deficiencies) 05/2012 - 07/2011
1	Genetic Risk Score 10/2021
1	Disease Progression 01/2021
1	Dysbiosis 01/2021
1	Atherosclerosis 01/2020
1	Glucosephosphate Dehydrogenase Deficiency 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Intellectual Disability (Idiocy) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2012

Drug/Important Bio-Agent (IBA)

16	Phenylalanine (L-Phenylalanine)FDA Link 02/2022 - 07/2011
13	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2010
9	Amino Acids FDA Link 02/2022 - 05/2012
5	caseinomacropeptideIBA 01/2021 - 11/2018
3	Caseins (Casein)FDA Link 01/2021 - 02/2019
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2021
2	Vitamin D FDA LinkGeneric 10/2021 - 01/2020
2	NitrogenIBA 09/2021 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 01/2020 - 05/2012
1	Vitamin D-Binding ProteinIBA 10/2021
1	hydroxide ionIBA 10/2021
1	C-Reactive ProteinIBA 01/2021
1	Butyrates (Butyrate)IBA 01/2021
1	pegvaliaseIBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	Peptides (Polypeptides)IBA 08/2020
1	LDL CholesterolIBA 01/2020
1	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	CholesterolIBA 01/2020
1	Mixed Function Oxygenases (Monooxygenases)IBA 06/2019
1	Dietary ProteinsIBA 04/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2017
1	EnzymesIBA 01/2016
1	CarbohydratesIBA 01/2016
1	sapropterin (tetrahydrobiopterin)FDA Link 07/2011
1	Prealbumin (Transthyretin)IBA 01/2010

Therapy/Procedure

1	Protein-Restricted Diet (Diet, Protein Restricted) 11/2020